Acquired by LabCorp MNG Laboratories was acquired by LabCorp in 2019, signaling access to larger distribution channels, established lab operations, and potential alignment with LabCorp’s customer base for expanded neurogenetic testing services.

Neuogenetic Focus Specializes in neurogenetic and complex biochemical testing with panels for movement disorders, epilepsy, muscular dystrophies, and intellectual disabilities, presenting cross-sell opportunities to labs, clinics, and hospitals seeking expansion of genetic diagnostics.

Tech Enabled Leverages a digital ecosystem including Genome MaNaGer database and Neurogenetic Answers reporting platform, offering scalable data-driven reporting and potential integration partnerships with EHRs and lab information systems.

Growth Through Partnerships Past collaborations with Pronto Diagnostics to market RNA sequencing services and mtDNA capabilities indicate openness to channel partnerships and distribution agreements that can be replicated in new regions or with additional service lines.

Market Position & Compliance Operating with CLIA and CAP certification and adherence to ACMG guidelines, MNG Laboratories presents a credible platform for enterprise partnerships, co-marketing with larger networks, and scalability in regulated markets.